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We report a high prevalence of non-C. albicans candidaemia and coagulase negative Staphylococcus septicaemia. High ß uconazole resistance along with high resistance to commonly used anti-bacterial antibiotics was also found.
Most of the studies have reported high ß uconazole and low amphotericin B resistance in Candida isolates. In our NICU, ß uconazole is used as the Þ rst line anti-fungal agent since last few years. This probably caused a shift towards non-C. albicans resistant strains of Candida spp. Chakrabarti et al. in a Þ ve years (1990) (1991) (1992) (1993) (1994) (1995) report said that isolation rate of non-C. albicans Candida has changed over the years: C. tropicalis (42.1%) and C. guillermondii (15.2%) were common in early 90s, but later there was increase in isolation rate of C. krusei (13%) and C. glabrata (2.2%) (1995).
5
Increased use of ß uconazole may have contributed partly to a shift in the incidence of systemic fungaemia due to yeast other than C. albicans which may be less responsive to ß uconazole therapy.
6
Nosocomial pathogens have shifted away from easily treatable bacteria towards more resistant bacteria and even to Candida spp. with fewer options for therapy. These shifts continue to present challenges for nosocomial infection control and prevention. 
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